Asian Journal of Transfusion Science
Home About Journal Editorial Board Search Current Issue Ahead of print Back Issues Instructions Subscribe Login  Users: 640 Print this page  Email this page Small font sizeDefault font sizeIncrease font size 
Ahead of Print

Maternal serum and cord blood anti-A and Anti-B antibody levels as a predictor of significant hyperbilirubinemia in newborns

1 Department of Paediatrics and Neonatology, Pondicherry Institute of Medical Sciences, Puducherry, India
2 Department of Pathology and Transfusion Medicine and Obstetrics and Gynaecology, Pondicherry Institute of Medical Sciences, Puducherry, India
3 Department of 2Obstetrics and Gynaecology, Pondicherry Institute of Medical Sciences, Puducherry, India

Correspondence Address:
Simon Kingsley,
No 83, Vaigai Street, Vasantham Nagar, Puducherry - 605 110
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/ajts.ajts_182_21

BACKGROUND: Hemolytic disease of the newborn (HDN) was more common due to Rh incompatibility. Its prevalence has decreased due to introduction of Immunoglobulin G (IgG) prophylaxis against RhD antigen. HDN due to ABO incompatibility has become more common. AIM: The aim of this study was to study the predictive value of umbilical cord serum and maternal serum anti-A and anti-B antibody titer for the occurrence of significant hyperbilirubinemia in newborns. SETTINGS AND DESIGN: This was a prospective cohort study which included 139 “O” blood group mothers and their offspring with A or B blood groups. MATERIALS AND METHODS: We analyzed the IgG anti-A, and anti-B antibody titers from cord blood and maternal serum and correlated them with features of significant hyperbilirubinemia. Positive predictive value (PPV), negative predictive value (NPV), sensitivity and specificity were calculated. RESULTS: Twenty-eight newborns out of 139 (20 %) developed significant hyperbilirubinemia and required phototherapy. One newborn required immunoglobulin infusion. Out of these 28 newborns' maternal serum, 22 (79%) newborns' maternal serum had IgG antibody titer of ≥128. Cord blood serum IgG antibody titer was 1:2 in all newborns, which was not significant. The direct Coombs test was positive in six (4%) newborns with maternal IgG antibody titer ≥128. CONCLUSION: Maternal IgG antibody titer was ≥1:128 and can predict significant hyperbilirubinemia in newborns with a sensitivity of 53.5%, specificity of 98.2%, PPV of 88%, NPV of 89%, and P value (P > 0.001).

Print this article
  Search Pubmed for
    -  Toshniwal PU
    -  Krishnan L
    -  Kingsley S
    -  Kurvila S
    -  Manikandan M
 Citation Manager
 Article Access Statistics
 Reader Comments
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded5    

Recommend this journal

Association Contact us | Sitemap | Advertise | What's New | Copyright and Disclaimer | Privacy Notice

2006 - Asian Journal of Transfusion Science | Published by Wolters Kluwer - Medknow
Online since 10th November, 2006